4.8 Review

The Inflammasomes

Journal

CELL
Volume 140, Issue 6, Pages 821-832

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2010.01.040

Keywords

-

Funding

  1. Australian National Health and Medical Research Council [ID 490993]
  2. Swiss National Science Foundation
  3. EU
  4. Institute of Arthritis Research, Lausanne

Ask authors/readers for more resources

Inflammasomes are molecular platforms activated upon cellular infection or stress that trigger the maturation of proinflammatory cytokines such as interleukin-1 beta to engage innate immune defenses. Strong associations between dysregulated inflammasome activity and human heritable and acquired inflammatory diseases highlight the importance this pathway in tailoring immune responses. Here, we comprehensively review mechanisms directing normal inflammasome function and its dysregulation in disease. Agonists and activation mechanisms of the NLRP1, NLRP3, IPAF, and AIM2 inflammasomes are discussed. Regulatory mechanisms that potentiate or limit inflammasome activation are examined, as well as emerging links between the inflammasome and pyroptosis and autophagy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available